Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bradpalm1 who wrote (923)	8/29/1998 11:31:00 AM
From: BigKNY3	Read Replies (3) of 1016

Brad and Mike: Since the VVUS Board is unfortunatley becoming Yahooed, I have returned to the Single Digits Board for a discussion of issues and honest opinions concerning VVUS and the ED market. Brad: The San Francisco Chronicle article does bring out the truth about Wole Fayemi....probably the worst Pharma analyst that you could ever hope to find. Wole's reports have been touting VVUS since his days as the VVUS analyst for Genesis ...which just happened to do investment banking for VVUS. In October, 1997, he moved to Cruttenden and Roth. Let's take a look at Wole Fayemi's unique insight into VVUS: March 3, 1997 (VVUS @ 27 5/8): Reiterated Strong Buy raising VVUS price target to $75 from $42 1/2. Forecasts MUSE sales at $140M (1997), $300M (1998) and $700M (1999). October 10, 1997 (VVUS @ 36 1/6): Despite the submission of Viagra NDA to the FDA in September, initiated coverage as new CR analyst on VVUS with a Buy and as price target of $75. April 23, 1998 (VVUS @ 8): Raised VVUS' Neutral rating to Strong Buy and set a 1998 price target of $23. Believes Viagra may be effective in only 50% of erectile dysfunction patients and that many patients "may turn to MUSE treatment for impotence"...VVUS "will reap rewards from PFE's marketing campaign which will likely increase the number of men seeking drugs for erectile dysfunction." May 1998: Wole Fayemi reportedly attempts to support his reports by calling "journalists with documented disclosures about deaths associated with Viagra's clinical trials." August 28, 1998 (VVUS @ 3 7/8): Maintains Strong Buy on VVUS BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next